dc.creatorSpilki F.R.
dc.creatorSilva A.D.
dc.creatorRuthner Batista H.B.C.
dc.creatorOliveira A.P.
dc.creatorWinkelmann E.
dc.creatorFranco A.C.
dc.creatorPorciuncula J.A.
dc.creatorRoehe P.M.
dc.date2005
dc.date2015-06-26T14:09:22Z
dc.date2015-11-26T14:09:12Z
dc.date2015-06-26T14:09:22Z
dc.date2015-11-26T14:09:12Z
dc.date.accessioned2018-03-28T21:09:46Z
dc.date.available2018-03-28T21:09:46Z
dc.identifier
dc.identifierPesquisa Veterinaria Brasileira. , v. 25, n. 1, p. 54 - 58, 2005.
dc.identifier0100736X
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-20044391823&partnerID=40&md5=78ef547774c784f43d4bea63a9713c9e
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/93776
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/93776
dc.identifier2-s2.0-20044391823
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1241179
dc.descriptionBovine herpesvirus type 1 (BoHV-1) is recognized as a major cause of respiratory, reproductive disease and abortion in cattle. Vaccination is widely applied to minimize losses induced by BoHV-1 infections; however, vaccination of dams during pregnancy with modified live virus (MLV) vaccines has been occasionally associated to abortions. We have previously reported the development of a BoHV-1 recombinant virus, constructed with basis on a Brazilian BoHV-1 (Franco et al. 2002a) from which the gene coding for glycoprotein E (gE) was deleted (gE-) by genetic manipulation. Such recombinant has been previously evaluated in its potential as a differential vaccine (gE-vaccine) that allows differentiation between vaccinated and infected animals. Here, in the first part of the present study, the safety of the gE-vaccine during pregnancy was evaluated by the intramuscular inoculation of 107.4 tissue culture 50% infective doses (TCID50) of the virus into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive), at different stages of gestation. Other 15 pregnant dams were kept as non-vaccinated controls. No abortions, stillbirths or fetal abnormalities were seen after vaccination. Seroconversion was observed in both groups of previously seronegative vaccinated animals. In the second part of the study, the potential of the gE-vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally with a larger amount (107.6TCID50) of the gE-vaccine (to increase chances of transmission) and mixed with other sixteen animals at the same age and body condition, in the same grazing area, at a population density equal to the average cattle farming density within the region (one cattle head per 10,000 m2), for 180 days. All animals were monitored daily for clinical signs. Serum samples were collected on days 0, 30, 60 and 180 post-vaccination. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE-vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle.
dc.description25
dc.description1
dc.description54
dc.description58
dc.descriptionBelknap, E.B., Walters, L.M., Kelling, C., Ayers, V.K., Norris, J., McMillend, J., Hayhowe, C., Collins, J.K., Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine (1999) Vaccine, 17, pp. 2297-2305
dc.descriptionBouma, A., De Jong, M.C.M., Kimman, T.G., Transmission of pseudorabies virus within pig populations is independent of the size of the population (1995) Prev. Vet. Med., 23, pp. 163-172
dc.descriptionCasal, J., Planasdemunt, L., Varo, J.A., Martín, M., The use of different vaccination schedules for sows to protect piglets against Aujeszky's disease (2004) Vet. Med. B, 51, pp. 8-11
dc.descriptionD'Arce, R.C.F., Almeida, R.S., Silva, T.C., Franco, A.C., Spilki, F., Roehe, P.M., Arns, C.W., Restriction endonuclease and monoclonal antibody characterization of Brazilian isolates of bovine herpesviruses types 1 and 5 (2002) Vet. Microbiol., 88, pp. 315-324
dc.descriptionEllis, J.A., Hassard, L.E., Cortese, V.S., Morley, P.S., Effects of perinatal vaccination on humoral and cellular immune responses in dams and young calves (1996) J. Am. Vet. Med. Assoc., 208, pp. 393-400
dc.descriptionFlores, E.F., Donis, R.O., Isolation of a mutant MDBK cell line resistant to bovine viral diarrhea virus infection due to a block in viral entry (1995) Virology, 208, pp. 565-575
dc.descriptionFlores, E.F., Osorio, F.A., Zanella, E.L., Kit, S., Kit, M., Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals (1993) J. Vet. Diagn. Invest., 5, pp. 534-540
dc.descriptionFranco, A.C., Rijsewijk, F.A.M., Flores, E.F., Weiblen, R., Roehe, P.M., Construction and characterization of a glycoprotein E deletion of bovine herpesvirus type 1.2 strain isolated in Brazil (2002) Braz. J. Microbiol., 33, pp. 274-278
dc.descriptionFranco, A.C., Spilki, F.R., Esteves, P.A., Lima, M., Weiblen, R., Flores, E.F., Rijsewijk, F.A.M., Roehe, P.M., A Brazilian glycoprotein E-negative bovine herpesvirus type 1.2a (BHV-1.2a) mutant is attenuated for cattle and induces protection against wild-type virus challenge (2002) Pesq. Vet. Bras., 22, pp. 135-140
dc.descriptionHage, J.J., Schukken, Y.H., Barkema, H.W., Benedictus, G., Rijsewijk, F.A.M., Wentink, G.H., Population dynamics of bovine herpesvirus infection a dairy herd (1996) Vet. Microbiol., 53, pp. 169-180
dc.descriptionGuy, J.S., Potgieter, L.N., Bovine herpesvirus-1 infection of cattle: Kinetics of antibody formation after intranasal exposure and abortion induced by the virus (1985) Am. J. Vet. Res., 46, pp. 893-898
dc.descriptionKaashoek, M., (1995) Marker Vaccines Against Bovine Herpesvirus 1 Infections, 155p. , Ph.D. Thesis, Utrecht University, Netherlands
dc.descriptionKleiboeker, S.B., Lee, S.M., Jones, C.A., Estes, D.M., Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine (2003) J. Am. Vet. Med Assoc., 222, pp. 1399-1403
dc.descriptionLomba, F., Vascoboinic, E., Zygraich, N., Immunization of pregnant dams with a temperature-sensitive mutant of the IBR Virus (1976) 6th Int. Congr. Diseases of Cattle, pp. 395-399. , Paris
dc.descriptionMars, M.H., De Jong, M.C.M., Van Oirschot, J.T., A gE-negative BHV-1 vaccine virus strain cannot perpetuate in cattle populations (2000) Vaccine, 18, pp. 2120-2124
dc.descriptionMcFelly, R.A., Merrit, A.M., Stearly, E.L., Abortion in a dairy herd vaccinated for infectious bovine rhinotracheitis (1964) Vet. Path., 1, pp. 7-17
dc.descriptionMiller, J.M., Whetstone, C.A., Van Der Maaten, M.J., Abortfacient property of bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction endonuclease analysis of viral DNA (1991) Am. J. Vet. Res., 52, pp. 458-461
dc.descriptionMiller, J.M., Whetstone, C.A., Bello, L.J., Lawrence, W.C., Whitbeck, J.C., Abortions in heifers inoculated with a thymidine kinase-negative recombinant of bovine herpesvirus 1 (1995) Am. J. Vet. Res., 56, pp. 870-874
dc.descriptionMitchell, D., An outbreak of abortion in a dairy herd following inoculation with an intramuscular infectious bovine rhinotracheitis virus (1964) Can. Vet. J., 26, pp. 8-14
dc.descriptionOdde, K.G., Survival of the neonatal calf. Factors influencing colostral and calf serum immunoglobulin levels (1988) Vet. Clin. North Am. Food Anim. Pract., 4, pp. 501-508
dc.descriptionPastoret, P.P., Babiuk, L.A., Misra, V., Griebel, P., Reactivation of temperature sensitive and non-temperature-sensitive infectious bovine rhinotracheitis vaccine virus with dexamethasone (1980) Infect. Immun., 29, pp. 483-488
dc.descriptionRoehe, P.M., (1991) Studies on the Comparative Virology of Pestiviruses, 361p. , Ph.D. thesis. University of Surrey, Guildford, UK
dc.descriptionSiebert, S., Auer, S., Heinem, E., Kretzdom, D., Strube, W., Marker vaccines - Opportunities for IBR control. Part I: BHV-1 infections - The problem (1995) Tierärztl. Umschau, 50, pp. 530-533
dc.descriptionSiebert, S., Auer, S., Heinem, E., Kretzdom, D., Strube, W., Marker vaccines - Opportunities for IBR control. Part II: Safety and efficacy of the gE-deleted Bayovac IBR marker vaccines (1995) Tierärztl. Umschau, 50, pp. 582-584
dc.descriptionStrube, W., Abar, B., Bergle, R.D., Safety aspects in the development of an infectious bovine rhinotracheitis marker vaccine. Non-target effects of live vaccines (1995) Dev. Biol. Stand., 84, pp. 75-81
dc.descriptionTurin, L., Russo, S., Poli, G., BHV-1: New molecular approaches to control a common and widespread infection (1999) Mol. Med., 5, pp. 261-284
dc.descriptionVan Drunen Littel-van Den Hurk, S., Parker, M.D., Massie, B., Van Den Hurk, J.V., Harland, R., Babiuk, L.A., Zamb, T.J., Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV (1993) Vaccine, 11, pp. 25-35
dc.descriptionVan Engelenburg, F.A.C., Kaashoek, M.J., Van Oirschot, J.T., Rijsewijk, F.A.M., A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period (1995) J. Gen. Virol., 76, pp. 2387-2392
dc.descriptionWentink, G.H., Van Oirschot, J.T., Verhoeff, J., Risk of infection with bovine herpes virus 1 (BHV-1): A review (1993) Vet. Quarterly, 15, pp. 30-33
dc.descriptionWhetstone, C.A., Wheeler, J.G., Reed, D.E., Investigation of possible vaccine-induced epizootics of infectious bovine rhinotracheitis, using restriction endonuclease analysis of viral DNA (1986) Am. J. Vet. Res., 47, pp. 1789-1795
dc.descriptionZuckermann, F.A., Husmann, R.J., Schwartz, R., Brandt, J., Mateu De Antonio, E., Martin, S., Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine (1998) Vet. Immunol. Immunopath., 63, pp. 57-67
dc.languageen
dc.publisher
dc.relationPesquisa Veterinaria Brasileira
dc.rightsaberto
dc.sourceScopus
dc.titleField Evaluation Of Safety During Gestation And Horizontal Spread Of A Recombinant Differential Bovine Herpesvirus 1 (bohv-1) Vaccine
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución